• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种强效的 DCN1-UBC12 相互作用小分子抑制剂,可选择性阻断泛素样蛋白连接酶 E3 复合物 CUL3 的 neddylation。

A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation.

机构信息

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, 48109, USA.

Department of Pathology, University of Michigan, Ann Arbor, Michigan, 48109, USA.

出版信息

Nat Commun. 2017 Oct 27;8(1):1150. doi: 10.1038/s41467-017-01243-7.

DOI:10.1038/s41467-017-01243-7
PMID:29074978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5658359/
Abstract

The Cullin-RING E3 ubiquitin ligases (CRLs) regulate homeostasis of ~20% of cellular proteins and their activation require neddylation of their cullin subunit. Cullin neddylation is modulated by a scaffolding DCN protein through interactions with both the cullin protein and an E2 enzyme such as UBC12. Here we report the development of DI-591 as a high-affinity, cell-permeable small-molecule inhibitor of the DCN1-UBC12 interaction. DI-591 binds to purified recombinant human DCN1 and DCN2 proteins with K values of 10-12 nM, and disrupts the DCN1-UBC12 interaction in cells. Treatment with DI-591 selectively converts cellular cullin 3 into an un-neddylated inactive form with no or minimum effect on other cullin members. Our data firmly establish a previously unrecognized specific role of the DCN1-UBC12 interaction for cellular neddylation of cullin 3. DI-591 is an excellent probe compound to investigate the role of the cullin 3 CRL ligase in biological processes and human diseases.

摘要

Cullin-RING E3 泛素连接酶(CRLs)调节约 20%的细胞蛋白的内稳态,其激活需要其 Cullin 亚基的 neddylation。Cullin 的 neddylation 由支架 DCN 蛋白通过与 Cullin 蛋白和 E2 酶(如 UBC12)的相互作用来调节。在这里,我们报告了 DI-591 的开发,它是一种高亲和力、细胞渗透性的小分子抑制剂,可抑制 DCN1-UBC12 相互作用。DI-591 以 10-12 nM 的 Kd 值与纯化的重组人 DCN1 和 DCN2 蛋白结合,并在细胞中破坏 DCN1-UBC12 相互作用。用 DI-591 处理可选择性地将细胞内 Cullin 3 转化为未 neddylated 的无活性形式,对其他 Cullin 成员几乎没有或没有影响。我们的数据明确确立了 DCN1-UBC12 相互作用在细胞内 Cullin 3 neddylation 中的以前未被认识到的特定作用。DI-591 是研究 Cullin 3 CRL 连接酶在生物学过程和人类疾病中的作用的极好的探针化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/9155f6ba1295/41467_2017_1243_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/4076277e0396/41467_2017_1243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/9c65d834ad39/41467_2017_1243_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/06a3074b3b0c/41467_2017_1243_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/5825778cdc39/41467_2017_1243_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/759bb2073b60/41467_2017_1243_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/9155f6ba1295/41467_2017_1243_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/4076277e0396/41467_2017_1243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/9c65d834ad39/41467_2017_1243_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/06a3074b3b0c/41467_2017_1243_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/5825778cdc39/41467_2017_1243_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/759bb2073b60/41467_2017_1243_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a19/5658359/9155f6ba1295/41467_2017_1243_Fig6_HTML.jpg

相似文献

1
A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation.一种强效的 DCN1-UBC12 相互作用小分子抑制剂,可选择性阻断泛素样蛋白连接酶 E3 复合物 CUL3 的 neddylation。
Nat Commun. 2017 Oct 27;8(1):1150. doi: 10.1038/s41467-017-01243-7.
2
High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein-Protein Interaction.高亲和力肽模拟物抑制剂的 DCN1-UBC12 蛋白-蛋白相互作用。
J Med Chem. 2018 Mar 8;61(5):1934-1950. doi: 10.1021/acs.jmedchem.7b01455. Epub 2018 Feb 26.
3
Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.靶向 DCN1-UBC12 蛋白-蛋白相互作用调控 Neddylation 通路。
Adv Exp Med Biol. 2020;1217:349-362. doi: 10.1007/978-981-15-1025-0_20.
4
Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein Interaction.开发高效、选择性和细胞活性的基于三唑并[1,5-a]嘧啶的抑制剂,靶向 DCN1-UBC12 蛋白质-蛋白质相互作用。
J Med Chem. 2019 Mar 14;62(5):2772-2797. doi: 10.1021/acs.jmedchem.9b00113. Epub 2019 Mar 4.
5
Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects.发现强效和选择性的 2-(苄硫基)嘧啶基 DCN1-UBC12 抑制剂,用于抗心脏纤维化作用。
J Med Chem. 2022 Jan 13;65(1):163-190. doi: 10.1021/acs.jmedchem.1c01207. Epub 2021 Dec 23.
6
Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.哌啶基脲类化合物通过化学方式控制 Cullin Neddylation1(DCN1)介导的 Cullin Neddylation 的缺陷。
J Med Chem. 2018 Apr 12;61(7):2680-2693. doi: 10.1021/acs.jmedchem.7b01277. Epub 2018 Mar 26.
7
Development of phenyltriazole thiol-based derivatives as highly potent inhibitors of DCN1-UBC12 interaction.苯并三唑硫醇类衍生物的开发作为 DCN1-UBC12 相互作用的高活性抑制剂。
Eur J Med Chem. 2021 May 5;217:113326. doi: 10.1016/j.ejmech.2021.113326. Epub 2021 Mar 12.
8
SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation.SCCRO(DCUN1D1)是泛素化E3复合物的一个重要组成部分。
J Biol Chem. 2008 Nov 28;283(48):33211-20. doi: 10.1074/jbc.M804440200. Epub 2008 Sep 30.
9
Evaluation of HZX-960, a novel DCN1-UBC12 interaction inhibitor, as a potential antifibrotic compound for liver fibrosis.评价 HZX-960,一种新型的 DCN1-UBC12 相互作用抑制剂,作为肝纤维化的潜在抗纤维化化合物。
Biochem Cell Biol. 2022 Aug 1;100(4):309-324. doi: 10.1139/bcb-2021-0585. Epub 2022 May 11.
10
Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation.Dcn1作为一种用于cullin泛素化修饰的支架型E3连接酶发挥作用。
Mol Cell. 2008 Jan 18;29(1):23-35. doi: 10.1016/j.molcel.2007.12.012.

引用本文的文献

1
PTEN neddylation aggravates CDK4/6 inhibitor resistance in breast cancer.PTEN的NEDDylation加重乳腺癌对CDK4/6抑制剂的耐药性。
Oncogene. 2025 Jun 18. doi: 10.1038/s41388-025-03468-z.
2
Inhibiting neddylation: A new strategy for tumor therapy.抑制NEDDylation:一种肿瘤治疗的新策略。
J Pharm Anal. 2025 May;15(5):101140. doi: 10.1016/j.jpha.2024.101140. Epub 2024 Nov 8.
3
Health position paper and redox perspectives - Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases.

本文引用的文献

1
Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.阻断N端乙酰化依赖性蛋白相互作用可抑制一种E3连接酶。
Nat Chem Biol. 2017 Aug;13(8):850-857. doi: 10.1038/nchembio.2386. Epub 2017 Jun 5.
2
UniProt: the universal protein knowledgebase.通用蛋白质知识库:UniProt
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169. doi: 10.1093/nar/gkw1099. Epub 2016 Nov 29.
3
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
健康立场文件与氧化还原观点——非传染性疾病中NRF2药理调节从 bench 到床边的转化
Redox Biol. 2025 Apr;81:103569. doi: 10.1016/j.redox.2025.103569. Epub 2025 Mar 3.
4
Protein neddylation and its role in health and diseases.蛋白质的类泛素化及其在健康和疾病中的作用。
Signal Transduct Target Ther. 2024 Apr 5;9(1):85. doi: 10.1038/s41392-024-01800-9.
5
Targeting cullin neddylation for cancer and fibrotic diseases.靶向泛素化用于癌症和纤维化疾病。
Theranostics. 2023 Sep 4;13(14):5017-5056. doi: 10.7150/thno.78876. eCollection 2023.
6
Discovery of neddylation E2s inhibitors with therapeutic activity.具有治疗活性的NEDDylation E2s抑制剂的发现。
Oncogenesis. 2023 Sep 16;12(1):45. doi: 10.1038/s41389-023-00490-2.
7
DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt/Catenin Pathway.DCUN1D1 是前列腺癌增殖和肿瘤生长的必需调节因子,通过 Cullin 1、3、4A 和 5 的 Neddylation 以及 Wnt/Catenin 通路的失调发挥作用。
Cells. 2023 Jul 31;12(15):1973. doi: 10.3390/cells12151973.
8
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions.针对 NEDD8-激活酶的癌症治疗:进展、临床试验、挑战和未来研究方向。
J Hematol Oncol. 2023 Jul 31;16(1):87. doi: 10.1186/s13045-023-01485-7.
9
Targeting neddylation as a novel approach to lung cancer treatment (Review).以靶向泛素化修饰作为一种新的肺癌治疗方法(综述)。
Int J Oncol. 2023 May;62(5). doi: 10.3892/ijo.2023.5513. Epub 2023 Apr 21.
10
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy.NEDD8缀合酶E2s:癌症治疗的关键靶点。
Cell Death Discov. 2023 Jan 23;9(1):23. doi: 10.1038/s41420-023-01337-w.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
4
Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.哺乳动物DCN型NEDD8 E3连接酶家族的特征分析。
J Cell Sci. 2016 Apr 1;129(7):1441-54. doi: 10.1242/jcs.181784. Epub 2016 Feb 18.
5
Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation.靶向Cullin-RING E3泛素连接酶进行药物研发:结构、组装与小分子调控
Biochem J. 2015 May 1;467(3):365-86. doi: 10.1042/BJ20141450.
6
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.富马酸二甲酯治疗复发缓解型多发性硬化症:综述
Ther Adv Neurol Disord. 2015 Jan;8(1):20-30. doi: 10.1177/1756285614564152.
7
Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8.处于作用状态的环状E3结构揭示了类泛素蛋白NEDD8的连接机制。
Cell. 2014 Jun 19;157(7):1671-84. doi: 10.1016/j.cell.2014.04.037.
8
Analysis of Flexibility and Hotspots in Bcl-xL and Mcl-1 Proteins for the Design of Selective Small-Molecule Inhibitors.用于设计选择性小分子抑制剂的Bcl-xL和Mcl-1蛋白的灵活性与热点分析
ACS Med Chem Lett. 2012 Feb 29;3(4):308-12. doi: 10.1021/ml200301w. eCollection 2012 Apr 12.
9
Hydrophobic Binding Hot Spots of Bcl-xL Protein-Protein Interfaces by Cosolvent Molecular Dynamics Simulation.通过共溶剂分子动力学模拟研究Bcl-xL蛋白-蛋白界面的疏水结合热点
ACS Med Chem Lett. 2011 Jan 13;2(4):280-4. doi: 10.1021/ml100276b. eCollection 2011 Apr 14.
10
Computational analysis of protein hotspots.蛋白质热点的计算分析。
ACS Med Chem Lett. 2010 Mar 25;1(3):125-9. doi: 10.1021/ml100026a. eCollection 2010 Jun 10.